Author: pattayadoctor

  • Dengue Fever in Thailand 2026: A Doctor’s Guide to Symptoms, Prevention, and Treatment

    What is Dengue Fever?

    Dengue fever is a mosquito-borne viral infection caused by four closely related dengue virus serotypes (DENV-1 through DENV-4) of the genus Flavivirus. It is transmitted primarily by the day-biting Aedes aegypti mosquito, with Aedes albopictus serving as a secondary vector. Dengue is now the most common vector-borne viral infection in tropical and subtropical regions worldwide, with over 100 countries affected across Southeast Asia, the Western Pacific, the Americas, and Africa.

    Epidemiology in Thailand

    Thailand remains one of the countries most heavily affected by dengue fever in Southeast Asia. As of March 2023, dengue is endemic in more than 100 countries, and the Americas, Southeast Asia, and the Western Pacific regions are the most seriously affected. Thailand reports tens of thousands of dengue cases annually, with significant seasonal variation. The rainy season from May through October creates ideal breeding conditions for Aedes mosquitoes, leading to dramatic surges in cases during these months.

    In Pattaya and surrounding Chonburi Province, dengue activity has historically been elevated due to the warm tropical climate, urban density, and tourism-related population movement. Dengue fever acquired in Southeast Asia typically presents with more severe hemorrhagic symptoms compared to infections acquired elsewhere, and cases can progress to dengue hemorrhagic fever or dengue shock syndrome.

    Symptoms: What to Watch For

    The incubation period after a dengue mosquito bite is typically 4 to 7 days, with symptoms lasting 2 to 7 days. Most infected individuals are asymptomatic or have only mild symptoms, but about 20% develop noticeable illness. The classic presentation includes:

    • Sudden high fever: Typically 40°C (104°F), often lasting 2 to 7 days

    • Severe headache: Especially pain behind the eyes (retro-orbital pain), which is characteristic of dengue

    • Severe muscle and joint pain: So severe that dengue was historically called “breakbone fever”

    • Nausea and vomiting: Common during the febrile phase

    • Rash: A macular or maculopapular rash that typically appears a few days after fever onset, involving the trunk and spreading outward

    • Mild bleeding: Nosebleeds, gum bleeding, or easy bruising

    • Fatigue and malaise: Profound tiredness that can persist for weeks

    Most patients recover fully within a week or so, though convalescence can be prolonged, with fatigue and weakness lasting several weeks.

    Dengue Hemorrhagic Fever and Warning Signs

    Secondary infection with a different dengue serotype carries a significantly higher risk of severe disease due to antibody-dependent enhancement. The World Health Organization now uses an updated classification system that identifies patients with dengue who have warning signs requiring careful observation:

    • Abdominal pain or tenderness

    • Persistent vomiting

    • Clinical fluid accumulation (abdominal distension, difficulty breathing)

    • Mucosal bleeding

    • Lethargy or restlessness

    • Liver enlargement greater than 2 centimeters below the right costal margin

    • Laboratory findings: increase in hematocrit greater than 20% of baseline with a rapid decrease in platelet count

    Without prompt fluid resuscitation, patients who progress to dengue shock syndrome can die within 12 to 24 hours. However, with appropriate hospital care, mortality is less than 1%.

    Diagnosis

    Early diagnosis (days 1 to 5 of illness) relies on:

    • NS1 antigen detection: Rapid antigen-based ELISA tests that can identify dengue virus non-structural protein 1 during the acute phase

    • RT-PCR: Reverse transcription polymerase chain reaction, the gold standard for detecting dengue viral RNA during the first week of illness

    After day 5, diagnosis shifts to serology:

    • Dengue IgM ELISA: Becomes positive after 4 to 5 days of illness

    • Dengue IgG ELISA: Indicates past infection or secondary infection

    Common laboratory findings include leukopenia (low white blood cell count), thrombocytopenia (platelet count below 100,000), and modest elevations of serum AST (aspartate aminotransferase) without significant liver synthetic dysfunction.

    Treatment

    There is no specific antiviral treatment for dengue. Management is entirely supportive:

    • Adequate hydration: Oral or intravenous fluids are the cornerstone of dengue management. Patients should drink plenty of fluids to maintain hydration and prevent shock from plasma leakage.

    • Paracetamol (acetaminophen): The recommended antipyretic for fever and pain relief. NSAIDs (ibuprofen, aspirin, diclofenac) should be avoided until dengue has been ruled out, as they increase the risk of bleeding.

    • Close monitoring: Patients with warning signs should be hospitalized for serial hematocrit measurements, platelet counts, and clinical observation.

    • Blood transfusion: May be needed in severe dengue with significant bleeding or profound thrombocytopenia.

    Prevention

    There is currently no universally available dengue vaccine, although several vaccines are in use in various countries. The most effective prevention strategies focus on mosquito control and personal protection:

    • Eliminate breeding sites: Empty, cover, or treat any container that collects standing water around the home — flower pots, buckets, discarded tires, water storage containers, and roof gutters

    • Use mosquito repellent: DEET-containing repellents applied to exposed skin

    • Wear protective clothing: Long sleeves and long pants, especially during daytime when Aedes mosquitoes are most active

    • Install window screens: Use screens on doors and windows, or sleep under insecticide-treated bed nets

    • Community action: Support local mosquito control programs and fogging operations

    Dr. Kijakarn notes that dengue is particularly dangerous in Pattaya due to its high tourism volume. “Many tourists are not aware of dengue risk and do not take prevention measures seriously. We see adults and children alike presenting with severe dengue during the rainy season. Anyone visiting or living in tropical Thailand should treat dengue prevention with the same seriousness as malaria prevention.”

    This article is for general information only and does not replace professional medical advice. If you are experiencing symptoms, please consult a healthcare provider.

  • Leptospirosis in Tropical Thailand: The Hidden Danger After Floods

    What is Leptospirosis?

    Leptospirosis is a zoonotic bacterial disease caused by spirochetes of the genus Leptospira. It is considered the most common worldwide infectious zoonosis, with cases reported across all continents except Antarctica. The disease affects both animals and humans, with rodents, cattle, dogs, and other mammals serving as reservoir hosts. The bacteria are shed in the urine of infected animals and can survive in warm, moist environments for weeks to months, making water and soil contaminated with infected animal urine the primary routes of transmission to humans.

    How People Get Infected

    Transmission occurs when bacteria in contaminated water or soil enter the body through cuts or scratches in the skin, through mucous membranes of the eyes, nose, or mouth, or, rarely, through ingestion of contaminated food or water. Activities that place people at high risk include:

    • Agricultural work, especially rice farming and sugarcane harvesting

    • Wading or swimming in contaminated freshwater (rivers, lakes, ponds, floodwater)

    • Occupational exposure in veterinarians, farmers, slaughterhouse workers, and sewage workers

    • Recreational activities like whitewater rafting, kayaking, and triathlons in tropical regions

    • Contact with animals or animal urine in endemic areas

    In Thailand, leptospirosis is a significant public health concern, particularly in rural agricultural communities during the rainy season. The northern and northeastern regions of Thailand report the highest incidence rates, with cases closely correlated with flooding and heavy rainfall.

    Symptoms: From Mild Flu-like to Life-Threatening

    Leptospirosis is known as “the great imitator” because its symptoms mimic many other diseases. The incubation period ranges from 2 to 30 days, typically 7 to 14 days.

    Classic (anicteric) leptospirosis — accounting for about 90% of cases — presents as a sudden-onset flu-like illness:

    • Sudden high fever: Often reaching 39°C to 40°C (102°F to 104°F)

    • Chills and rigors: Often sudden and dramatic

    • Severe muscle aches: Particularly affecting the calves, lower back, and thighs — calf tenderness is a classic finding

    • Severe headache: Often frontal and frontal-temporal

    • Nausea, vomiting, and diarrhea: Gastrointestinal symptoms are common

    • Rash: Macular or petechial, appearing in some cases

    • Conjunctival suffusion: Red eyes without purulent discharge — this is a highly characteristic finding of leptospirosis

    • Jaundice: Yellowing of the skin and eyes (absent in anicteric form)

    Severe leptospirosis (Weil’s disease) occurs in approximately 5% to 10% of cases and can be fatal:

    • Severe jaundice with liver failure

    • Acute kidney injury requiring dialysis

    • Pulmonary hemorrhage — diffuse alveolar hemorrhage can be rapidly fatal

    • Meningitis and meningoencephalitis

    • Cardiac arrhythmias and myocarditis

    • Disseminated intravascular coagulation (DIC)

    • Multiorgan failure and death (mortality in Weil’s disease is 5% to 15%, and up to 50% in severe pulmonary hemorrhagic syndrome)

    Diagnosis

    Diagnosis is challenging because early symptoms overlap with many tropical diseases. Key diagnostic tools include:

    • Culture: The definitive diagnostic method, but Leptospira grows slowly (up to 13 weeks) and requires specialized media, making it impractical for acute management

    • PCR: Detects Leptospira DNA in blood (first week) and urine (second week onward); provides rapid results

    • Microscopic Agglutination Test (MAT): The gold standard serological test, detecting agglutinating antibodies; requires paired sera showing a four-fold rise in antibody titer

    • Rapid diagnostic tests: IgM-based ELISA and lateral flow assays provide faster results but may have variable sensitivity

    • Complete blood count: May show thrombocytopenia and elevated C-reactive protein

    • Chemistry panel: Elevated creatinine (kidney injury), bilirubin, and liver enzymes

    Leptospirosis must be differentiated from malaria, typhoid fever, dengue fever, scrub typhus, viral hepatitis, and other febrile illnesses — all of which are common in tropical Thailand.

    Treatment

    • Mild disease: Oral doxycycline (100 mg twice daily for 7 days) or oral amoxicillin/ampicillin. Most patients can be treated at home with antibiotics, fluids, and supportive care.

    • Severe disease: Intravenous ceftriaxone (1-2 g daily) or IV penicillin G. Hospitalization is essential for close monitoring of renal function, fluid balance, and respiratory status.

    • Supportive care: Aggressive fluid and electrolyte management, renal replacement therapy (dialysis) if needed, and careful monitoring for pulmonary hemorrhage.

    Early antibiotic treatment — even within the first five days of illness — shortens the clinical course, reduces complications, and decreases the duration of bacteremia and bacterial shedding.

    Prevention

    • Avoid contact with potentially contaminated water: Especially during and after flooding. Do not swim or wade in floodwater, rivers, or ponds in endemic areas.

    • Wear protective clothing: Waders, boots, and gloves when working in waterlogged soil or with animals

    • Cover wounds: Use waterproof dressings on any cuts or abrasions before contact with potentially contaminated water

    • Antibiotic prophylaxis: Doxycycline 200 mg weekly during high-risk activities (e.g., rafting, military exercises in endemic areas)

    • Control rodents: Reduce rodent populations around homes and workplaces

    • Vaccination: Vaccines are available in some countries for high-risk occupational groups, but no vaccine is widely available globally

    Dr. Kijakarn emphasizes the connection between flooding and leptospirosis in Thailand. “Every major flood in Thailand is followed by a spike in leptospirosis cases. We see farmers and flood cleanup workers presenting with high fever, muscle pain, and jaundice. Anyone who has been wading in floodwater and develops fever should seek medical care immediately and specifically mention their water exposure — this dramatically speeds up diagnosis and treatment.”

    This article is for general information only and does not replace professional medical advice. If you are experiencing symptoms, please consult a healthcare provider.

  • Scrub Typhus in Southeast Asia: What Every Doctor and Traveler Needs to Know

    What is Scrub Typhus?

    Scrub typhus is an acute febrile illness caused by the bacterium Orientia tsutsugamushi, a member of the rickettsial group of pathogens. It is transmitted to humans through the bite of infected chigger mites (larval trombiculid mites) that feed on rodents, the natural reservoir of the organism. Scrub typhus is found across a vast “tsutsugamushi triangle” stretching from northern Japan and eastern Russia in the north, through southern China and the Indian subcontinent, to northeastern Australia and the western Pacific islands. It is particularly endemic in Southeast Asia, including Thailand, where it is a recognized cause of acute undifferentiated febrile illness, especially in rural and agricultural areas.

    Epidemiology in Thailand

    Scrub typhus is a significant cause of acute undifferentiated fever in Thailand, particularly in the northern and northeastern regions where rice paddies, forests, and brushy areas provide ideal habitat for the chigger mites. Cases peak during the cool, dry season from November to April, when agricultural activities such as rice harvesting bring people into close contact with chigger-infested areas.

    The disease is increasingly recognized as one of the most common causes of acute encephalitis and febrile illness with multiorgan involvement in Southeast Asia. In Thailand, scrub typhus is often underdiagnosed because its symptoms overlap with dengue, leptospirosis, malaria, and typhoid fever — all of which are prevalent in the same geographic areas.

    Symptoms: The Classic Triad and Beyond

    The incubation period is typically 1 to 3 weeks after a chigger bite. The disease has an abrupt onset with the following characteristic features:

    • Sudden high fever: Often reaching 39°C to 40°C (102°F to 104°F), with an acute, dramatic onset

    • Severe headache: Often frontal, persistent, and refractory to analgesics

    • Myalgias: Muscle aches, particularly of the back and shoulders

    • The eschar: At the site of the chigger bite, a papule develops that becomes necrotic and forms a characteristic black crusty lesion called an eschar. The groin and abdomen are the most common sites, followed by the chest and axillae. The eschar is typically painless with an erythematous halo and may have lymphangitis radiating from it. While this finding is highly suggestive of scrub typhus, it was only described in approximately 19% of a South Korean study series, and it is often located in hidden areas (groin, axillae, scalp) and can be missed on examination.

    • Rash: A maculopapular rash that typically appears around days 5 to 7 of illness, beginning on the trunk and spreading to the extremities. The rash may be subtle or absent in some cases.

    • Lymphadenopathy: Regional lymph nodes near the eschar are commonly enlarged and tender

    • Splenomegaly: Enlargement of the spleen

    Severe scrub typhus can involve multiple organ systems and may be fatal without treatment:

    • Encephalitis: Confusion, altered mental status, seizures

    • Pneumonitis: Respiratory distress, acute respiratory distress syndrome (ARDS)

    • Myocarditis: Cardiac inflammation, arrhythmias

    • Meningitis: Nuchal rigidity, photophobia

    • Hepatitis: Elevated liver enzymes, jaundice

    • Acute renal failure

    Without treatment, fever typically subsides spontaneously after about 2 weeks, but the mortality rate may be 10% to 30%. With appropriate antibiotic treatment, mortality drops below 1%.

    Diagnosis

    Diagnosis is primarily clinical, supported by laboratory and serological findings:

    • Serological assays: Indirect fluorescent antibody (IFA), enzyme-linked immunosorbent assay (ELISA), and rapid diagnostic tests using lateral flow chromatography are the mainstays of laboratory diagnosis. IFA is considered the gold standard but results take days to weeks.

    • PCR: Polymerase chain reaction amplification of Orientia genes from eschar tissue is highly effective for early diagnosis. Blood PCR is less sensitive but useful in eschar-negative cases.

    • Blood tests: Typical findings include elevated C-reactive protein, mild transaminitis (elevated AST/ALT), thrombocytopenia, and hyponatremia. Lymphocytosis and an elevated white blood cell count may be present.

    • Chest X-ray: May show interstitial infiltrates in cases with pneumonitis

    Scrub typhus must be differentiated from dengue, leptospirosis, typhoid fever, malaria, rickettsialpox, murine typhus, and other causes of acute undifferentiated fever. The presence of an eschar, lymphocytosis, and elevated C-reactive protein may help distinguish scrub typhus from dengue.

    Treatment

    Scrub typhus responds dramatically to antibiotic therapy, and treatment should never be delayed pending laboratory confirmation when clinical suspicion is high:

    • First-line treatment: Doxycycline 100 mg orally twice daily. Treatment should continue until the patient has been afebrile for at least 3 days (typically 7 to 14 days total). A rapid defervescence — often within 24 to 48 hours — is characteristic of successful treatment and serves as a useful diagnostic clue.

    • Alternative for mild disease: Azithromycin 500 mg once daily for 3 days. Shorter courses are associated with higher relapse rates.

    • Severe disease: Minocycline 100 mg intravenously twice daily, or doxycycline if IV is not available. Chloramphenicol (500 mg four times daily) is an alternative but carries a risk of relapse and serious adverse effects including aplastic anemia.

    Relapse occurs in up to 20% of cases, especially with short-course therapy or in patients who stop antibiotics too soon after fever resolves. Patients should be instructed to complete the full course of treatment and return if fever recurs.

    Prevention

    • Avoid chigger habitats: Chiggers thrive in grassy, brushy, and wooded areas. Avoid sitting on the ground in tall grass, brush, or forest floor, especially during the cool, dry season.

    • Use insect repellent: DEET-based or permethrin-treated clothing provides effective protection against chigger bites

    • Wear protective clothing: Long sleeves, long pants tucked into socks, and closed shoes when working or hiking in endemic areas

    • Shower immediately: Showering and changing clothes after potential exposure can wash off unengaged chiggers before they bite

    • Clear vegetation: Keep grass and brush trimmed around homes, especially in rural areas

    • Chemoprophylaxis: Daily doxycycline 100 mg has been used for military personnel and others with prolonged high-risk exposure, but is not generally recommended for tourists or the general public

    Dr. Kijakarn notes that scrub typhus is frequently misdiagnosed as dengue in Thailand. “Both diseases cause high fever in the same geographic areas, but the treatments are completely different. If a patient has been hiking, farming, or spending time in grassy areas and presents with fever, we specifically look for the eschar. Missing the diagnosis and delaying doxycycline can be fatal, especially in children and elderly patients. We always ask about outdoor exposure before assuming dengue.”

    This article is for general information only and does not replace professional medical advice. If you are experiencing symptoms, please consult a healthcare provider.

  • Influenza Outbreak 2026: What You Need to Know About the H3N2 Subclade K Wave

    It is mid-2026, and influenza is back with a vengeance. What started as a mild seasonal uptick has now escalated into one of the most significant flu outbreaks the world has seen in over a decade. Hospitals across Asia, Europe, and North America are reporting surges in respiratory cases that far exceed normal seasonal patterns, and public health officials are sounding the alarm.

    The current outbreak is driven primarily by a mutated strain of influenza A(H3N2), specifically a new subclade designated as K. This variant has proven remarkably effective at evading the immune protection conferred by last season’s flu vaccine. According to the U.S. Centers for Disease Control and Prevention, the 2025–2026 flu season has already caused approximately 25 million illnesses and 20,000 deaths in the United States alone — including the tragic loss of 79 children. Similar trends are being reported across Southeast Asia, where Thailand, Vietnam, and Malaysia have all reported elevated influenza activity well above the seasonal baseline.

    Dr. Kijakarn, a physician at a major hospital in Pattaya, notes that the clinical presentation of this year’s flu has some unexpected features. “We’re seeing patients who are much sicker than typical seasonal flu,” he explains. “The fever tends to run higher, the cough is more persistent, and recovery is taking longer. Many patients report lingering fatigue for two to three weeks after the acute phase has passed.”

    Why is the 2026 flu season so severe?

    Several factors are converging to make this flu season particularly challenging:

    Vaccine mismatch: The H3N2 subclade K mutation has reduced the effectiveness of the current flu vaccine. While the vaccine still provides meaningful protection against severe disease and hospitalization, its ability to prevent infection altogether has declined significantly. Experts estimate protection against infection is now around 30–40%, down from the usual 50–60%.

    Post-pandemic immune debt: After years of reduced influenza circulation during the COVID-19 pandemic, population-wide immunity to flu viruses waned. As normal travel and social interactions resumed in 2024–2025, the virus found a much larger pool of susceptible hosts than usual.

    Co-circulation with other viruses: This season has also seen unusual co-circulation of influenza with respiratory syncytial virus (RSV), adenovirus, and SARS-CoV-2. This “twindemic” scenario strains healthcare systems and makes differential diagnosis more complex.

    Delayed peak timing: Historically, flu peaks between November and January in the Northern Hemisphere. This year, the peak has been delayed into spring, keeping the virus circulating for a longer period and extending the window of transmission.

    Symptoms: How to tell flu from a cold or COVID-19

    The symptoms of the 2026 flu strain overlap significantly with common cold, COVID-19, and other respiratory infections. Here is what to watch for:

    • Sudden onset: Flu hits fast. A cold usually develops gradually over a day or two. Flu, by contrast, can leave you feeling fine one hour and debilitated the next.

    • High fever: Most adults with flu get a fever of 38°C (100.4°F) or higher. Younger children and older adults may not always develop a fever, which can delay diagnosis.

    • Body aches: The deep muscle and joint pain associated with flu is often more severe than with a cold. Many patients describe feeling like they “have been hit by a truck.”

    • Fatigue: Flu-related fatigue is profound and can last for weeks. It is distinct from the milder tiredness of a common cold.

    • Respiratory symptoms: Dry cough, sore throat, and nasal congestion are common with flu, but the cough tends to be more persistent and can last four to six weeks.

    • Gastrointestinal symptoms: While more common in children, nausea, vomiting, and diarrhea are sometimes seen with influenza, particularly with H1N1 strains.

    What should you do if you suspect you have flu?

    Get tested. Rapid influenza diagnostic tests can provide results in 15–30 minutes at most clinics. Knowing whether you have influenza, COVID-19, or another respiratory virus guides treatment decisions and helps prevent spread.

    Start antiviral medication early. Oseltamivir (Tamiflu) and baloxavir (Xofluza) are most effective when started within 48 hours of symptom onset. For patients at high risk — those over 65, pregnant women, people with chronic conditions, and young children — early antiviral treatment can prevent serious complications including pneumonia, sepsis, and death.

    Rest and hydrate. These old-fashioned measures are not optional. Your immune system needs energy and fluids to fight the virus. Pushing through flu “like a man” only prolongs recovery.

    Isolate. Influenza is highly contagious. Stay home for at least 24 hours after your fever breaks without using fever-reducing medication. In this outbreak, consider extending isolation to five days or until symptoms improve, whichever comes first.

    Prevention in the 2026 outbreak

    Even with a partially mismatched vaccine, flu shots remain the single most effective prevention tool. The WHO has recommended the same three-strain formulation for the 2026–2027 season — H1N1, H3N2, and B/Victoria lineage — which is very similar to last year’s vaccine.

    Beyond vaccination, standard preventive measures matter more than ever in this outbreak:

    • Wear a well-fitting mask (N95/KN95 or surgical) in crowded indoor spaces

    • Wash hands frequently and avoid touching your face

    • Improve ventilation in indoor spaces — open windows, use HEPA filters

    • Stay home when sick

    • Keep distance from people who are coughing or sneezing

    Dr. Kijakarn emphasizes that Pattaya, with its high volume of international visitors, is at particular risk. “Tourists who are asymptomatic or mildly ill can spread the virus to vulnerable local populations — elderly residents, young children, and immunocompromised patients. We urge visitors to get vaccinated before travel and to seek medical care promptly if they develop symptoms.”

    The 2026 influenza outbreak is a stark reminder that respiratory viruses do not disappear — they evolve. By staying informed, getting vaccinated, and practicing good hygiene, you can reduce your risk of infection and help protect the broader community.

    This article is for general information only and does not replace professional medical advice. If you are experiencing symptoms, please consult a healthcare provider.

  • How to deal with Gaslighting from toxic people?

    Toxic people can be challenging to deal with, but it’s essential to remember that everyone has the potential to behave in toxic ways at times. 

    However, if someone consistently engages in toxic behaviors like gaslighting , the first is to identify and then step to manage.

    Gaslighting is a form of manipulation where someone makes you question your own perception of reality. It can be challenging to recognize, but once you’ve identified it, you can take steps to protect yourself.

    First, it’s essential to identify the toxic behavior. Gaslighting can manifest as denying that something was said or done, blaming you for their own actions, or making you feel like you’re going crazy. Once you’ve identified it, you can take the following steps:

    1. Set clear boundaries: Communicate clearly and assertively about what behavior is acceptable and what is not. Be firm but respectful.

    2. Practice self-care: Engage in activities that nourish and support your physical, emotional, and mental well-being.

    3. Seek support: Reach out to trusted friends, family, or a mental health professional for guidance and encouragement.

    4. Consider limiting or eliminating contact: If the toxic behavior persists despite your efforts to address it, it may be necessary to limit or eliminate contact with the person. 

    source: oxford-handbook-of-psychiatry

  • Novel treatment in Asthma and COPD with Biologic agents.

    Novel treatment in Asthma and COPD with Biologic agents.

    ​Asthma management has evolved significantly with the introduction of biologic therapies, especially for patients with severe, uncontrolled asthma . Like type 2 asthma with stimulations to T helper 2 and some cytokines releasing which cause an uncontrolled , severe asthma or exacerbation of COPD. These agents target specific components of the immune system involved in airway inflammation, offering tailored treatment options. Below is an overview of notable biologic agents, including recent advancements

    Omalizumab (Xolair) : Omalizumab target at IgE , preventing the IgE – receptor action. Approved for using in various IgE mediated food allergy , chronic spontaneous urticaria (CSU) and severe asthma , Chronic rhinosinusitis with nasal Polyp (CRSwNP)

    Tezepelumab (Tezspire): Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin (TSLP), a cytokine implicated in initiating airway inflammation. Approved for use in individuals aged 12 and older with severe asthma, it has demonstrated efficacy in reducing asthma exacerbations across various patient populations. Dosage 210 mg sc every 4 weeks.

    Mepolizumab (Nucala) : Injection .The agent interact with interleukin-5 receptor (IL-5R) to prevent IL-5 targeted receptor . Using in severe asthma in child and adult , CRSwNP , Eosinophilic granulomatosis with polyangiitis (EGPA) , Hypereosinophilic syndrome (HES) dosage 100-300 mg sc every 4 weeks.

    Benralizumab (Fasenra): Benralizumab targets the interleukin-5 receptor (IL-5R) on eosinophils, leading to their depletion. It is approved for the treatment of severe eosinophilic asthma. Recent studies suggest that benralizumab may be more effective than traditional oral steroids during acute asthma attacks, reducing the need for further treatment by 30%. , also useful for EGPA

    Astegolimab: Astegolimab is an investigational monoclonal antibody targeting the ST2 receptor, which is involved in the inflammatory response associated with asthma. It is being evaluated for its potential to treat asthma and chronic obstructive pulmonary disease (COPD), particularly in patients with low eosinophil counts.

    Dupilumab (Dupixent): Dupilumab is a monoclonal antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling, key drivers of type 2 inflammation. While primarily approved for conditions like eczema, atopic dermatitis , severe asthma , CRSwNP , Prurigo nodularis , EoE and recent developments have expanded its use to treat COPD to prevent exacerbation(300 mg alternate week), marking it as the first biologic treatment for this condition.

    These biologic agents represent significant advancements in asthma treatment, offering personalized approaches based on the underlying inflammatory pathways of the disease. Ongoing research continues to refine their efficacy and safety profiles, aiming to enhance outcomes for patients with severe asthma.

  • Acute Febrile Illness (AFI) Causes

    Acute Febrile Illness (AFI): Causes

    Acute Febrile Illness (AFI) is characterized by a sudden onset of fever and associated systemic symptoms lasting for a short duration, typically less than two weeks. It is a common presentation in clinical settings and can be caused by a wide range of infectious and non-infectious etiologies. Proper identification of the underlying cause is crucial for effective management and treatment. This article provides a comprehensive list of all possible causes of AFI, including rare causes.

    Causes of Acute Febrile Illness (AFI)

    Table 1: Causes of AFI (Including Rare Causes)

    TypeCauseExamples
    Infectious CausesBacterial InfectionsTyphoid Fever, Pneumonia, Meningitis, UTIs, Endocarditis, Brucellosis, Tularemia, Anthrax, Q Fever, Melioidosis, Leprosy, Lyme Disease, Rickettsial infections (Rocky Mountain Spotted Fever, Scrub Typhus)
    Viral InfectionsDengue, Influenza, COVID-19, Chikungunya, Measles, Mumps, Rabies, Hantavirus, Viral Hemorrhagic Fevers (Ebola, Marburg), West Nile Virus, Zika, Crimean-Congo Hemorrhagic Fever (CCHF), Lassa Fever, Nipah Virus
    Parasitic InfectionsMalaria, Leptospirosis, Trypanosomiasis, Toxoplasmosis, Babesiosis, Schistosomiasis, Amoebiasis, Fascioliasis, Filariasis, Echinococcosis
    Fungal InfectionsCandidiasis, Histoplasmosis, Coccidioidomycosis, Cryptococcosis, Blastomycosis, Paracoccidioidomycosis, Sporotrichosis, Aspergillosis
    Non-Infectious CausesAutoimmune DisordersSystemic Lupus Erythematosus (SLE), Rheumatic Fever, Still’s Disease, Sarcoidosis, Vasculitis, Adult-onset Still’s Disease (AOSD), Polyarteritis Nodosa
    Malignancies (Neoplastic)Lymphoma, Leukemia, Renal Cell Carcinoma, Hepatocellular Carcinoma, Multiple Myeloma, Metastatic Cancers, Paraneoplastic Syndromes
    Drug-Induced FeversAntibiotics, Anticonvulsants, Chemotherapy, NSAIDs, Antiarrhythmics, Vaccines, Biologics, Illicit Drug Reactions
    Environmental CausesHeat StrokeHeat Stroke, Hyperthermia due to extreme environments, Neuroleptic Malignant Syndrome (NMS)
    Hyperthermia from ToxinsCocaine, Amphetamines, Anticholinergics, Salicylate Toxicity, Serotonin Syndrome
    Unknown CausesFever of Unknown Origin (FUO)Idiopathic Fevers, Familial Mediterranean Fever (FMF), Adult-onset Immunodeficiency Syndrome (AOIS), Periodic Fever Syndromes

    Pathophysiology

    1. Infectious Causes (Most Common)

    • Bacterial Infections:
      • Pathophysiology: Activation of immune response via endotoxins or exotoxins leading to cytokine release (IL-1, TNF-α).
      • Examples:
        • Typhoid Fever (Salmonella typhi)
        • Pneumonia (Streptococcus pneumoniae, Haemophilus influenzae)
        • Meningitis (Neisseria meningitidis, Streptococcus pneumoniae)
        • Urinary Tract Infections (E. coli)
    • Viral Infections:
      • Pathophysiology: Viral replication causing cell lysis, immune activation, and cytokine storm.
      • Examples:
        • Dengue Fever
        • Influenza
        • COVID-19 (SARS-CoV-2)
        • Chikungunya
        • Measles, Mumps
    • Parasitic Infections:
      • Pathophysiology: Immune response to parasitic antigens; inflammation and tissue damage.
      • Examples:
        • Malaria (Plasmodium spp.)
        • Leptospirosis (Leptospira spp.)
        • Trypanosomiasis (African Sleeping Sickness)
    • Fungal Infections:
      • Pathophysiology: Invasive fungal infections trigger inflammatory responses, especially in immunocompromised individuals.
      • Examples:
        • Candidiasis
        • Histoplasmosis

    2. Non-Infectious Causes

    • Autoimmune Disorders:
      • Pathophysiology: Autoimmune activation causing systemic inflammation and fever.
      • Examples:
        • Systemic Lupus Erythematosus (SLE)
        • Rheumatic Fever
        • Still’s Disease
    • Malignancies (Neoplastic):
      • Pathophysiology: Release of pyrogens from cancer cells or tumor necrosis.
      • Examples:
        • Lymphoma
        • Leukemia
        • Renal Cell Carcinoma (Paraneoplastic syndromes)
    • Drug-Induced Fevers:
      • Pathophysiology: Hypersensitivity reactions or alteration in thermoregulation.
      • Examples:
        • Antibiotics (e.g., Beta-lactams)
        • Anticonvulsants (e.g., Phenytoin)
        • Chemotherapy agents

    3. Environmental Causes

    • Heat Stroke:
      • Pathophysiology: Failure of thermoregulation leading to hyperthermia and systemic inflammatory response.
    • Hyperthermia from Toxins:
      • Pathophysiology: Direct effect on hypothalamic regulation or increased metabolic rate.
      • Examples:
        • Cocaine, Amphetamines
        • Anticholinergic overdose

    4. Unknown/Idiopathic Causes

    • Fever of Unknown Origin (FUO):
      • Pathophysiology: Persistent fever (>3 weeks) without clear etiology despite thorough investigation.

    References

    1. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th Edition.
    2. Harrison’s Principles of Internal Medicine, 21st Edition.
    3. Kumar & Clark’s Clinical Medicine, 10th Edition.
    4. Fauci AS, et al. (2020). Harrison’s Principles of Internal Medicine. McGraw-Hill.
    5. Shapiro DS, et al. (2019). Infectious Disease: A Clinical Short Course. McGraw-Hill.
    6. Longo DL, et al. (2019). Fever of Unknown Origin. New England Journal of Medicine.
  • The Impact of PM2.5 on Platelet Activity and Cardiovascular Health

    The Impact of PM2.5 on Platelet Activity and Cardiovascular Health

    Introduction

    Fine particulate matter (PM2.5), comprising particles with a diameter of 2.5 micrometers or less, is a significant air pollutant known to penetrate deep into the respiratory tract and enter the bloodstream. Chronic exposure to PM2.5 has been linked to various adverse health outcomes, particularly affecting cardiovascular health. Emerging research indicates that PM2.5 exposure may influence platelet activity, thereby contributing to cardiovascular diseases.

    How PM2.5 Affects Platelets:

    Increased levels of inflammatory cytokines like IL-6 and TNF-α from PM2.5 exposure can enhance platelet activation.

    Inflammation and Oxidative Stress:

    PM2.5 exposure induces systemic inflammation and oxidative stress, which can activate platelets and promote their aggregation.

    Pro-thrombotic Effects:

    Activated platelets can contribute to blood clot formation, increasing the risk of thrombosis, which is a common underlying mechanism for heart attacks and strokes.

    Altered Platelet Count and Function:

    Some studies have reported changes in platelet count (either increased or decreased) and altered platelet function in individuals exposed to high levels of PM2.5.

    Endothelial Dysfunction:

    PM2.5 exposure can damage the endothelial cells lining blood vessels, which in turn promotes platelet adhesion and activation.

    Inflammatory Cytokine Release:

    Increased levels of inflammatory cytokines like IL-6 and TNF-α from PM2.5 exposure can enhance platelet activation.

    The activation and aggregation of platelets due to PM2.5 exposure have significant health implications:

    Multiple studies have found that short-term and long-term exposure to PM2.5 is associated with increased platelet aggregation, higher mean platelet volume (MPV), and elevated levels of platelet activation markers (e.g., P-selectin).

    Increased Thrombosis Risk: Enhanced platelet activity can lead to the formation of blood clots, increasing the risk of thrombosis, heart attacks, and strokes. from the study : Long-term exposure to PM2.5 and cardiovascular disease incidence and mortality in an Eastern Mediterranean country :The cohort comprised 3081 participants over 35 years old who were free of CVDs. Mean three-year PM2·5 exposure for the cohort was measured at 45.28 μg/m3, ranging from 20.01 to 69.80 μg/m3. The median time period for conducting necessary follow-ups was 12.3 years for the whole population. In well-adjusted models, 10 μg/m3 increase in PM2.5 corresponded to a 3% increase in the incidence rate of CVDs [0.95 CI = 1.016, 1.036] but No consistent association was observed between PM2.5 concentration and fatal CVD (fatal AMI, fatal stroke, SCD (Sudden Cardiac Death)) and all-cause mortality.
    Increase Platelet production :
    A study involving 362,396 Taiwanese adults found that each 10 μg/m³ increase in the 2-year average PM2.5 concentration was associated with a 0.42% increase in platelet counts in men and a 0.49% increase in women. This suggests that long-term exposure to PM2.5 may enhance blood coagulability.

    Cardiovascular Disease Incidence: Long-term exposure to PM2.5 has been associated with higher rates of cardiovascular diseases, partly due to its effect on platelet activation.

    reference :

    1. https://ehjournal.biomedcentral.com/articles/10.1186/s12940-021-00797-w
    2. https://pubmed.ncbi.nlm.nih.gov/29753251/
  • flu vaccination this year 2025

    flu vaccination this year 2025

    Flu vaccination this year 2025 :

    Start the flu season now in Thailand and you should have all 4 strains of flu vaccination now.

    Influenza Vaccine Strain Recommendations for 2025 by WHO

    The World Health Organization (WHO) has announced the recommended influenza vaccine strains for the 2025 influenza season, with separate recommendations for the Southern Hemisphere and Northern Hemisphere. These recommendations are based on the analysis of global influenza virus surveillance data by the WHO Global Influenza Surveillance and Response System (GISRS) and are critical for ensuring vaccine effectiveness against circulating strains .

    Southern Hemisphere (2025 Season)


    For the 2025 Southern Hemisphere influenza season, the WHO recommends the following strains for trivalent vaccines:

    Egg-based vaccines:

    A/Victoria/4897/2022 (H1N1)pdm09-like virus

    A/Croatia/10136RV/2023 (H3N2)-like virus

    B/Austria/1359417/2021 (B/Victoria lineage)-like virus

    Cell culture-, recombinant protein-, or nucleic acid-based vaccines:

    A/Wisconsin/67/2022 (H1N1)pdm09-like virus

    A/District of Columbia/27/2023 (H3N2)-like virus

    B/Austria/1359417/2021 (B/Victoria lineage)-like virus

    For quadrivalent vaccines, the B/Yamagata lineage component remains unchanged:

    B/Phuket/3073/2013 (B/Yamagata lineage)-like virus .

    Northern Hemisphere (2025-2026 Season)


    The WHO has not yet finalized the recommendations for the 2025-2026 Northern Hemisphere influenza season. However, a meeting is scheduled for February 2025 to analyze global influenza activity and determine the vaccine composition. This meeting will involve experts from WHO Collaborating Centres, regulatory agencies, and vaccine manufacturers .

    Key Changes and Rationale


    H3N2 Update: The H3N2 component for the Southern Hemisphere has been updated to A/Croatia/10136RV/2023 (H3N2)-like virus to reflect the latest circulating strains .

    B/Yamagata Exclusion: The B/Yamagata lineage has not been detected in circulation since March 2020, leading to a shift toward trivalent vaccines in many regions. However, quadrivalent vaccines still include this component for regions where it remains in use .

  • Health effects of pm2.5

    Health effects of pm2.5

    Health Effects of PM2.5
    Mortality and Morbidity:

    Long-term exposure to PM2.5 contributed to 4.14 million deaths globally in 2019, accounting for 62% of all air pollution-related deaths. This represents a 23% increase over the past decade(2).

    In China, PM2.5 exposure in 2019 was linked to 21,113 all-cause deaths, with significant declines in cardiovascular and respiratory deaths compared to 2015 due to improved air quality measures(9).

    Cardiovascular and Respiratory Diseases:

    PM2.5 is associated with premature death in individuals with heart or lung disease, nonfatal heart attacks, irregular heartbeat, and aggravated asthma(3).

    It can penetrate deep into the lungs and bloodstream, causing inflammation, oxidative stress, and genotoxicity, which contribute to cardiovascular and respiratory disorders(10)(12).

    Systemic Effects:

    Beyond the lungs and heart, PM2.5 exposure affects the renal, neurological, gastrointestinal, and reproductive systems. It has been linked to chronic kidney disease, neurodegenerative disorders like Alzheimer’s, and adverse birth outcomes(10)(12).

    Vulnerable Populations:

    Children, older adults, and individuals with preexisting conditions are more susceptible to PM2.5-related health issues. Low socioeconomic status and minority populations often face higher exposure levels(3).

    Mechanisms of PM2.5-Induced Health Damage
    Oxidative Stress and Inflammation:

    PM2.5 triggers the production of reactive oxygen species (ROS), leading to cellular damage and inflammation. This process is a key mechanism behind its toxic effects(10)(12).

    Immune System Activation:

    Exposure to PM2.5 activates immune responses, including the release of pro-inflammatory cytokines like IL-6 and TNF-α, which exacerbate tissue damage(10).

    Genotoxicity:

    PM2.5 can cause DNA damage, increasing the risk of cancer and other chronic diseases(12).


    Can I go Outdoor during PM 2.5 ?

    Yes , if air quality is fine (0-12 microgram/m3 PM2.5)

    What pm2.5 range should I consider to avoid prolong outdoor exercise?

    Moderate (12-35 µg/m³):
    Air Quality: Acceptable
    Recommendation: Generally safe for most people. Those who are unusually sensitive to air pollution should consider reducing prolonged or heavy exertion.

    When I have to avoid outdoor exercise?

    Unhealthy for Sensitive Groups (35-55 µg/m³):
    Air Quality: May cause health issues for sensitive individuals (e.g., people with asthma, heart disease, or respiratory conditions).
    Recommendation: Sensitive groups should reduce prolonged or heavy outdoor exertion. Healthy individuals can usually continue outdoor activities but should monitor for symptoms like coughing or shortness of breath.
    Unhealthy (55-150 µg/m³):
    Air Quality: Everyone may begin to experience health effects.
    Recommendation: Limit prolonged or heavy exertion outdoors. Sensitive groups should avoid outdoor exercise. Consider indoor activities instead.

    What level is very hazardous level?

    Very Unhealthy (150-250 µg/m³):
    Air Quality: Health warnings of emergency conditions.
    Recommendation: Avoid outdoor exercise. Everyone, especially sensitive groups, should stay indoors and keep activity levels low.
    Hazardous (250+ µg/m³):
    Air Quality: Health alert: everyone may experience more serious health effects.
    Recommendation: Stay indoors and avoid all physical activity outdoors.

    reference

    (1)ScienceDirect2024/12/011

    An update on adverse health effects from exposure to PM2.5

    The suggested mechanisms by which PM 2.5 induces adverse health effects include the initiation of oxidative stress, inflammation, genotoxicity, and immunotoxicity. These findings provide insights into the mechanisms linking PM 2.5 exposure and health effects.

    (2)State of Global Air2

    Health Impacts of PM2.5 – State of Global Air

    Health effects attributable to long-term exposure to PM 2.5 include ischemic heart disease, lung cancer, chronic obstructive pulmonary disease (COPD), lower-respiratory infections (such as pneumonia), stroke, type 2 diabetes, and adverse birth outcomes.

    (3)U.S. Environmental Protection Agency2024/07/163

    Health and Environmental Effects of Particulate Matter (PM)

    Particles less than 10 micrometers in diameter pose the greatest problems, because they can get deep into your lungs, and some may even get into your bloodstream. Fine particles (PM2.5) are the main cause of reduced visibility (haze).

    (4)ScienceDirect2023/05/014

    Overview of PM2.5 and health outcomes: Focusing on components, sources …

    This study provides a systematic overview of (1) the relationship between PM 2.5 exposure and health risks, (2) the sources and toxic effects of different PM 2.5 compositions, and (3) the health impacts of interactions between PM 2.5 and other pollutants.

    (5)ScienceDirect2021/10/155

    Assessing the health impacts attributable to PM2.5 and ozone pollution …

    Specifically, the objectives of this study are (1) to assess the annual PM 2.5 – and ozone-related health impacts on all Chinese cities from 2015 to 2020; (2) to discuss the spatio-temporal characteristics of health impacts in Chinese cities; (3) to evaluate the health effects of air pollution prevention and control in China during the 13th-FYP …

    (6)ScienceDirect2016/06/016

    The health effects of ambient PM2.5 and potential mechanisms

    Epidemiological and toxicological studies have shown that PM 2.5 does not only induce cardiopulmonary disorders and/or impairments, but also contributes to a variety of other adverse health effects, such as driving the initiation and progression of diabetes mellitus and eliciting adverse birth outcomes.

    (7)Nature2023/12/157

    First close insight into global daily gapless 1 km PM2.5 pollution …

    Exposure to PM 2.5 (particulate matter with aerodynamic diameters ≤ 2.5 µm) pollution is associated with a variety of circulatory and respiratory diseases 2, 3, 4, 5, contributing to 4…

    (8)pmc.ncbi.nlm.nih.gov8

    Toxicological Effects of Fine Particulate Matter (PM2.5): Health Risks …

    Previous studies focused on investigating particulate matter with aerodynamic diameter ≤ 2.5 µm (PM2.5) have shown the risk of disease development, and association with increased morbidity and mortality rates. The current review investigate …

    (9)Nature2024/05/169

    Changes of PM2.5 and O3 and their impact on human health in the …

    PM 2.5 and O 3 pose significant risks to human health, as they can irritate the respiratory tract, leading to symptoms such as coughing, wheezing, and shortness of breath 13. These pollutants…

    (10)link.springer.com2023/05/2410

    Toxicological Effects of Fine Particulate Matter (PM2.5): Health Risks …

    The current review investigate epidemiological and experimental findings from 2016 to 2021, which enabled the systemic overview of PM2.5’s toxic impacts on human health. The Web of Science database search used descriptive terms to investigate the interaction among PM2.5 exposure, systemic effects, and COVID-19 disease.

    (11)WHO2021/09/2211

    WHO global air quality guidelines: particulate matter (‎PM2.5 and PM10 …

    In 2015, the World Health Assembly adopted a landmark resolution on air quality and health, recognizing air pollution as a risk factor for noncommunicable diseases such as ischaemic heart disease, stroke, chronic obstructive pulmonary disease, asthma and cancer, and the economic toll they take.

    (12)PubMed12

    The health effects of ambient PM2.5 and potential mechanisms

    The proposed underlying mechanisms whereby PM2.5 causes adverse effects to public health include inducing intracellular oxidative stress, mutagenicity/genotoxicity and inflammatory responses. The present review aims to provide an brief overview of new insights into the molecular mechanisms linking ambient PM2.5 exposure and health effects …

    (13)mdpi.com2022/10/1013

    Health Effects of PM2.5 Exposure in China from 2004 to 2018: A … – MDPI

    A systematic review shows that there are 30 diseases and 46 health effect outcomes with clear concentration–response relationships with PM2.5 in China. Seven health effects were investigated by meta-analysis.

    (14)pmc.ncbi.nlm.nih.gov14

    Recent Insights into Particulate Matter (PM2.5)-Mediated Toxicity in …

    According to the most recent data, fine particulate matter, or PM 2.5, is responsible for nearly 4 million deaths globally from cardiopulmonary illnesses such as heart disease, respiratory infections, chronic lung disease, cancers, preterm births, and other illnesses.

    (15)ACS Publications2021/12/2315

    Tracking PM2.5 and O3 Pollution and the Related Health Burden in China …

    Recent clean air policies brought great health benefits dominated by decrease in PM 2.5, but short-term O 3 -associated deaths has become nonnegligible. 1. Introduction. Air pollution has been a threat to public health and the ecological system in China.

    (16)Springer2022/03/1616

    Health Effects of Long-Term Exposure to Ambient PM2.5 in Asia-Pacific …

    Health effects of long-term exposure to ambient PM 2.5 vary with regions, and 75% of the deaths attributable to PM 2.5 were estimated in Asia-Pacific in 2017. This systematic review aims to summarize the existing evidence from cohort studies on health effects of long-term exposure to ambient PM 2.5 in Asia-Pacific.

    (17)Nature2024/12/1917

    Health burdens related to emission sources and cross … – Nature

    The health impacts of PM 2.5 and ozone can be attributed to their precursor emissions, by source category, species, and region. Such analysis is valuable, as it allows for targeted and…

    (18)pmc.ncbi.nlm.nih.gov2016/01/1918

    The impact of PM2.5 on the human respiratory system – PMC

    Understanding how PM2.5 leads to respiratory diseases will assist in preventing and diagnosing the corresponding health issues and the evolution of more effective methods and technologies for the treatment of PM2.5-induced diseases.

    (19)The Lancet19

    The Lancet Countdown on PM2·5 pollution-related health impacts of China …

    We calculated the PM 2·5 concentrations and compared the health impacts and implementation costs between two scenarios that reflect CO 2 and air pollutant emissions—the reference (REF) scenario (no climate policy) and the NDC scenario (100% realisation of NDC targets: CO 2 emission intensity needs to be about 40% below 2010 emissions by 2030 …

    (20)PubMed2022/03/2220

    Health Effects of Long-Term Exposure to Ambient PM2.5 in Asia-Pacific …

    This systematic review aims to summarize the existing evidence from cohort studies on health effects of long-term exposure to ambient PM 2.5 in Asia-Pacific. Recent findings: In Asia-Pacific, 60 cohort studies were conducted in Australia, Mainland China, Hong Kong, Taiwan, and South Korea.

    (21)ScienceDirect2023/06/1521

    Tracing the sources of PM2.5-related health burden in China

    Fine particulate matter (PM2.5) poses a major environmental risk to human health. We estimated PM2.5-related premature deaths in 30 Chinese provinces in 2020 using an integrated exposure response model based on monitored concentrations and obtained regional and sectoral contributions based on the atmospheric transport of the atmospheric …

    (22)U.S. Environmental Protection Agency2024/08/0122

    Clinical Outcomes Related to Particulate Matter Exposure and …

    Hundreds of scientific studies have found that breathing in fine particulate matter (PM2.5) over the course of hours to days (short-term) and months to years (long-term) can lead to a variety of health effects, including harmful effects on blood vessels and the heart.

    (23)ACS Publications2016/04/1123

    Economic Impacts from PM2.5 Pollution-Related Health Effects in China …

    This study evaluates the PM2.5 pollution-related health impacts on the national and provincial economy of China using a computable general equilibrium (CGE) model and the latest nonlinear exposure–…

    (24)ACS Publications2024/06/0524

    Association between Long-Term Exposure to PM2.5 Inorganic Chemical …

    Long-term exposure to higher levels of PM 2.5 inorganic compositions was associated with significantly increased cardiopulmonary mortality, with SO 42– potentially being the primary contributor. These findings offer insights into how PM 2.5 sources impact health, aiding the development of more effective governance measures. CC-BY-NC-ND 4.0 .

    (25)AGU Publications2022/03/1425

    A Health Impact and Economic Loss Assessment of O3 and PM2.5 Exposure …

    Based on ozone (O 3) and fine particulate matter concentration (PM 2.5) monitoring data in 331 Chinese cities from 2015 to 2020, this study evaluated the health effects and the corresponding economic losses of O 3 and PM 2.5 pollution on three health endpoints.

    (26)Cell Press2024/10/2526

    Long-term exposure to PM2.5 has significant adverse effects on …

    Evidence suggests that long-term exposure to fine particulate matter (PM 2.5) may be an important risk factor for developing asthma. However, inconsistencies in findings from earlier epidemiological studies have left this potential health risk under debate.

    (27)ACS Publications27

    Economic Impacts from PM2.5 Pollution-Related Health Effects: A Case …

    In this study, we examine the health and economic impacts from PM 2.5 pollution under various air pollution control strategies and climate policies scenarios in the megacity of Shanghai.

    (28)ScienceDirect2023/05/2028

    Substantial short- and long-term health effect due to PM2.5 and the …

    For PM 2.5 constituents, organic carbon leads to the most short-term exposure deaths. We find an amplified health effect due to compound events compared to single events. Heavy pollution events of fine particulate matter (PM 2.5) frequently occur in China, seriously affecting the human health.

    (29)BMC Public Health2025/01/2929

    Ambient air pollution and Alzheimer’s disease and … – BMC Public Health

    Stratified analyses by Global North–South divide and human development index were performed to explore the potential inequity in air pollution impacts. During 1990–2019, the global ASMR, DALYs and O3 increased by 0.11%, 0.09%, and 0.17% per year, respectively. In contrast, PM2.5 and NO2 decreased by 0.33% and 0.14% per year, respectively.

    (30)PubMed2022/03/1530

    Long-term PM2.5 exposure and various health outcomes: An umbrella …

    Adverse effects from exposure to particulate matter <2.5 μm in diameter (PM 2.5) on health-related outcomes have been found in a range of experimental and epidemiological studies. This study aimed to assess the significance, validity, and reliability of the relationship between long-term PM 2.5 exposure and various

    (31)ScienceDirect2020/05/1531

    Acute and chronic health impacts of PM2.5 in China and the influence of …

    Although heavy pollution episodes and their related health impacts attract substantial public attention, we find that the long-term health impacts caused by ambient PM 2.5 concentration are more important for the overall public health burden. These results suggest that policy makers need not only to control and prevent heavy pollution episodes …

    (32)UN News2025/02/0732

    Toxic air threatens children’s lives across East Asia and the Pacific …

    Nearly half of PM2.5 pollution in the worst-affected countries comes from the burning of fossil fuels, biomass, and agricultural waste – also major contributors to climate change. As extreme weather events worsen due to climate change, air pollution is expected to become an even greater threat, UNICEF warned. Impacts beyond health

    (33)Springer2024/05/0233

    The effect of fine particulate matter (PM2.5) pollution on health …

    This research introduces PM2.5 pollution into the intergenerational health transmission model, and estimates its impact on health inequality in China using Ordered Logit Regression (OLR) and Multi-scale Geographically Weighted Regression (MGWR) model.

    (34)Nature2025/02/0434

    Rising socio-economic costs of PM2.5 pollution and medical service …

    The harmful impact of fine particulate matter (PM2.5) air pollution on public health remains a pressing concern. Detrimental effects of such pollution on elderly populations can be exacerbated by …

    (35)PubMed2025/02/0735

    Long-Term Exposure to Fine Particulate Matter (PM2.5 … – PubMed

    Background: The increasing incidence of precocious puberty is a major health challenge for Chinese children, while related risk factors remain less well explored. Exposure to ambient fine particulate matter (PM2.5) is a leading environmental hazard in China. Although certain components of PM2.5 have been reported to be endocrine disruptors for sex hormones, population-based evidence is still …

    (36)ACP2025/02/0436

    Impacts of meteorology and emission reductions on haze pollution during …

    Fine particulate matter (PM 2.5) is a critical issue for both policymakers and the general public due to its widespread presence and adverse impacts on human health (Lelieveld et al., 2018), agriculture productivity (Dong and Wang, 2023), and the Earth’s radiation balance (Li et al., 2022; Yang et al., 2021).The formation and accumulation of anthropogenic PM 2.5 result from a complex …

    (37)Medical Xpress2025/02/0737

    Air pollution’s dual threat: Health and economic impacts on aging societies

    Air pollution is a growing health issue worldwide, and its impacts are often underestimated in aging societies like Japan. … Rising socio-economic costs of PM2.5 pollution and medical service …

    (38)pmc.ncbi.nlm.nih.gov38

    Long- and Short-Term Exposure to PM2.5 and Mortality: Using Novel …

    Multiple studies in the United States and worldwide have shown associations between exposure to ambient particulate matter (PM) and adverse health effects. 1–6 These adverse health effects include asthma, 7 cardiovascular problems, 3,8–12 respiratory infections, 13–17 lung cancer, and mortality. 18–22

    (39)ScienceDirect2022/03/0139

    Assessing the evolution of PM2.5 and related health impacts resulting …

    The mean PM 2.5 concentration in the first half of 2021 was 34 μg/m 3 (the World Health Organization (WHO) guideline suggests that PM 2.5 should not exceed 5 μg/m 3 annual mean). Therefore, it is necessary to review the long-term evolution of air pollution in China and the effect of policies implemented to better formulate new plans and …

    (40)Springer2024/08/0240

    Short-term Exposure to PM2.5 and Cardiorespiratory Mortality and …

    Exposure to ambient fine particulate matter (PM2.5) is a substantial environmental health issue for urban inhabitants in Ho Chi Minh City (HCMC). The effects of short-term exposure to ambient PM2.5 on cardiorespiratory mortality and morbidity were determined in HCMC by a retrospective, hospital-based, unidirectional, and symmetric bidirectional case-crossover study. Ambient PM2.5 …

    (41)Harvard T.H. Chan School of Public Health2025/01/3141

    The health impacts of wildfires: Frequently asked questions | Harvard T …

    One study estimated chronic health impacts from indoor exposures to various air pollutants and found PM 2.5 to account for the greatest burden, … Look for one that measures airborne particles (PM2.5) and airborne gases (TVOCs). These are imperfect measures, but will give you a sense of how your space is being impacted or not. For more …

    (42)ScienceDirect2019/09/0142

    Human health impact and economic effect for PM2.5 … – ScienceDirect

    Exposure to hazardous PM 2.5 would not only trigger human health impact, but also result in an economic loss for both society and individual. In this study, the PM 2.5-related health impact and corresponding economic loss are assessed in

    (43)ScienceDirect43

    Population exposure evaluation and value loss analysis of PM2.5 and …

    These results were based on well-continued large spatial scale PM 2.5 and O 3 concentration data, and population data, and highlighted the significant impacts of both on public health in